home

News

 

Jun 27 2011 Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
Nov 24 2010 Glycotex, Inc. Awarded Cash Grant Under the U.S. Government Qualifying Therapeutic Discovery Program
Feb 11 2010 GLYCOTEX, INC. EXPANDS PATENT PORTFOLIO IN ADVANCED WOUND HEALING INDICATIONS
Apr 07 2009 GLYCOTEX’ INVESTIGATIONAL COMPOUND GLYC-101 ACHIEVES ACCELERATED WOUND CLOSURE BASED ON INTERIM ANALYSIS
Oct 21 2008 GLYCOTEX REPORTS FIRST PATIENT ENROLLMENT IN PHASE IIB STUDY OF LEAD PRODUCT CANDIDATE GLYC-101 FOR WOUND HEALING
Oct 17 2008 GLYCOTEX FINALIZES COLLABORATION AGREEMENT WITH ADVANCED MEDICAL SOLUTIONS
Mar 13 2008 GLYCOTEX COMPLETES ENROLLMENT IN PHASE IIA STUDY OF LEAD PRODUCT CANDIDATE GLYC-101 FOR WOUND HEALING
Jan 16 2008 GLYCOTEX, INC. RECEIVES $0.5 MILLION FROM SECOND TRANCHE OF PRIVATE SHARE PLACEMENT
Jan 07 2008 GLYCOTEX, INC., OBTAINS ACTIVE IND FROM US FOOD AND DRUG ADMINISTRATION FOR GLYC-101 WOUND HEALING COMPOUND